VIPAR inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the VIPAR (Vps33a Interacting Protein, Apical-basolateral polarity Regulator) protein. VIPAR is a critical component of the molecular machinery involved in intracellular trafficking, particularly in regulating the assembly and function of the HOPS (homotypic fusion and vacuole protein sorting) and CORVET (class C core vacuole/endosome tethering) complexes. These complexes are essential for the proper sorting and fusion of vesicles, ensuring the accurate distribution of cargo within cellular compartments like endosomes and lysosomes. VIPAR plays a role in maintaining cell polarity and is involved in the apical-basolateral trafficking of proteins, which is crucial for cellular organization and function. By inhibiting VIPAR, these compounds interfere with vesicle transport processes that are key to maintaining intracellular trafficking and protein sorting.
The mechanism of action of VIPAR inhibitors involves binding to functional regions of the VIPAR protein, preventing it from interacting with other components of the vesicle tethering machinery, such as Vps33a. This inhibition disrupts the role of VIPAR in facilitating vesicle docking and fusion, leading to alterations in cellular processes dependent on efficient cargo transport and organelle function. Researchers use VIPAR inhibitors to investigate the protein's specific roles in vesicular trafficking and how its disruption impacts cellular organization and polarity. By blocking VIPAR activity, these inhibitors provide valuable insights into the molecular mechanisms governing intracellular trafficking and the complex regulation of protein sorting within cells. Understanding how VIPAR controls these processes enhances knowledge of cellular architecture and the maintenance of functional compartmentalization in diverse biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that by inhibiting multiple kinases can reduce the phosphorylation of VIPAR, thus affecting its function in cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can downregulate AKT signaling, potentially reducing VIPAR activity as it is linked to membrane trafficking that is influenced by PI3K/AKT pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
By inhibiting MEK1/2, this compound can interfere with the ERK/MAPK pathway, which may regulate the subcellular localization and function of VIPAR. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts the Golgi apparatus structure and function, which could indirectly inhibit VIPAR by altering the Golgi-dependent trafficking it is involved in. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibits the N-WASP-Arp2/3 complex, potentially reducing actin polymerization and thus might affect VIPAR's role in vesicle trafficking and cytoskeleton organization. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
A GTPase inhibitor that can disrupt dynamin-mediated endocytosis, possibly leading to reduced recycling of VIPAR-containing vesicles. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A CDC42 inhibitor that can influence actin organization and membrane trafficking, potentially affecting VIPAR's role in these cellular processes. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibits cytohesin exchange factors, potentially impairing ARF-mediated vesicle trafficking and indirectly affecting VIPAR's function. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Interferes with clathrin-mediated endocytosis which could impact VIPAR's involvement in vesicular transport pathways. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Binds to actin monomers and inhibits polymerization, potentially affecting VIPAR's function related to actin-dependent vesicle movement. | ||||||